ACM BIOLABS PTE. LTD.
Last Updated: 13 Apr 2026
ACM Biolabs is a biotechnology company focused on developing innovative medicines through next-generation targeted delivery. Our proprietary polymer-based delivery platform technology enables the development of prophylactic treatment and therapeutic vaccines for infectious diseases, as well as personalized cancer treatment. By leveraging our experienced team, strategic locations in leading biotechnology hubs, and commitment to challenging the status quo of targeted delivery, we aim to revolutionize the way medicines are developed and delivered. Our targeted delivery approach results in lower doses and fewer side effects, making our medicines safer and more well-tolerated. With a focus on ease of manufacturing and storage, our platform technology has the potential to transform the way medicines are developed and brought to market.
Country of registration | Singapore |
Registration number | 201317235H |
Local SIC | |
Incorporation date | 26 Jun 2013 |
Company age | 12 years 11 months |
Official entity type | Private Limited Company |
No. of officers | 19 |
Contact
Address:
8 EU TONG SEN STREET, #16-98, THE CENTRAL, Singapore 059818
Access Key Decision Makers
This is the legal entity page of ACM BIOLABS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- ACM BIOLABSView MoreSingaporeACM Biolabs is a biotechnology company focused on developing innovative medicines through next-generation targeted delivery. Our proprietary polymer-based delivery platform technology enables the development of prophylactic treatment and therapeutic vaccines for infectious diseases, as well as personalized cancer treatment. By leveraging our experienced team, strategic locations in leading biotechnology hubs, and commitment to challenging the status quo of targeted delivery, we aim to revolutionize the way medicines are developed and delivered. Our targeted delivery approach results in lower doses and fewer side effects, making our medicines safer and more well-tolerated. With a focus on ease of manufacturing and storage, our platform technology has the potential to transform the way medicines are developed and brought to market.
This is the legal entity page of ACM BIOLABS PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | C.C. YANG & CO. |
Revenue | > 10m |
Share Capital - Ordinary shares | SGD 377 |
Share Capital - Preference shares | SGD 26,266,885 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of ACM BIOLABS PTE. LTD.?
- Where is ACM BIOLABS PTE. LTD.'s headquarter?
- What is ACM BIOLABS PTE. LTD.'s contact number?
- What ACM BIOLABS PTE. LTD.'s spending power?
- Does ACM BIOLABS PTE. LTD. have a presence in the domain it operates in?